VP Enterprise Data & Information Management

Regeneron Pharmaceuticals, Inc.; Village of Tarrytown (NY); On-site; USD 250,000 - 450,000; Full time

Benefits offered by this job

Equity awards

Bonus plans

Pension/retirement benefits

Health and wellness programs

Paid time off

Job summary

Regeneron Pharmaceuticals, Inc is seeking a visionary leader for Enterprise Data & Information Management. This VP will build Regeneron’s data program from the ground up, ensuring data integrity, governance, and AI readiness at enterprise scale.

The role requires deep expertise in data governance, MDM, metadata, and a federated data architecture, with strong leadership across global teams and regulatory awareness for GxP environments.

Qualifications

• BS/BA degree in a related field.
• 20+ years leading enterprise data management, governance, or data architecture initiatives.
• Deep expertise in data governance, master data management, metadata management, and data quality.
• Hands‑on architectural depth in federated data architecture and multimodal data infrastructure.
• Experience with GxP data compliance in regulated life sciences preferred.

Responsibilities

• Set enterprise data quality standards and governance policy for Regeneron's data estate.
• Define strategic direction for the enterprise semantic layer across domains.
• Lead enterprise glossary and taxonomy programs with centralized governance.
• Oversee knowledge graph strategy and investment for enterprise use cases.
• Own federated data ecosystem architecture balancing centralized governance with domain‑owned data products.
• Enforce GxP‑compliant data standards and privacy across the data layer.
• Build and lead a multidisciplinary data organization spanning governance, engineering, and architecture.

Skills

Data governance

Data architecture

Metadata management

Enterprise data quality

GxP compliance

Leadership

Communication

Education

BS/BA degree in a related field

Tools

Knowledge Graphs

Semantic Layer

Federated data architecture

MDM

Job description

Regeneron's Enterprise Data & AI organization is newly established and moving fast, built to drive AI transformation and adoption at scale across every part of the enterprise. This is a high-visibility, high-velocity position where the work is directly tied to business and scientific impact. The VP of Enterprise Data & Information Management is the guardian of Regeneron's most differentiated AI asset: our data. This role ensures Regeneron's data advantage, anchored by Regeneron's proprietary scientific and clinical assets and external data partnerships, is structured, governed, and AI-ready at enterprise scale. This leader will ensure the integrity, accessibility, and governance of Regeneron's enterprise data assets and enterprise data products. The VP of Enterprise Data & Information Management will build Regeneron's enterprise data program from the ground up and establish foundational data capabilities and governance structures. This leader will set and enforce enterprise data quality standards, policies, and compliance requirements; manage the enterprise data catalog, metadata infrastructure, and semantic layer; partner with business units to mature data as a foundational and differentiating capability for AI at scale; ensure compliant, GxP-ready data pipelines; and build the federated multimodal infrastructure that makes production-grade AI possible. Data must be not just available, but trustworthy, traceable, and ready for enterprise AI use. This position reports to the SVP Chief AI Officer. This leader owns the multi-year enterprise data strategy and holds executive accountability for it, including hiring and directing the Executive Director, Enterprise Data, who leads day‑to‑day governance and engineering execution against that strategy.

Core Responsibilities

• Data Governance, Cataloging, MDM & Quality Sets the enterprise data quality standard and governance policy for Regeneron's data estate, and decides where the organization invests in master data management and cataloging capability to meet it.
• Enterprise Semantic Layer Sets the strategic direction and investment priority for the enterprise semantic layer, deciding which domains and data models are standardized centrally versus federated to business units.
• Business Glossary & Taxonomy Sets the enterprise standard and investment priority for Regeneron's business glossary and taxonomy program, determining which domains require centrally governed vocabulary.
• Knowledge Graphs Sets the enterprise strategy and investment case for knowledge graph infrastructure, prioritizing which domains and use cases justify the build.
• Federated Data Ecosystem Owns the enterprise architecture strategy for a federated, AI-ready data ecosystem, setting the standards that balance domain‑owned data products against centralized governance and a graph‑enabled semantic layer.
• GxP‑Compliant Data Standards Sets enterprise policy for GxP‑compliant data standards and holds executive accountability for regulated data pipeline compliance across the data layer.
• Data Privacy & Security Sets enterprise policy and risk tolerance for data privacy and security across the data estate and holds executive accountability for Regeneron's data protection posture.
• People & Organizational Leadership Builds, develops, and leads a multidisciplinary data organization spanning data governance, data engineering, metadata management, and data architecture, including hiring and directing the Executive Director, Enterprise Data, and setting the multi‑year strategy the organization executes against.

Qualifications

• BS/BA degree in a related field required.
• 20+ years leading enterprise data management, data governance, or data architecture organizations, with a demonstrated track record of building data foundations that enable AI and analytics at scale.
• Deep expertise in data governance frameworks, master data management, metadata management, and enterprise data quality, including experience establishing these disciplines from scratch in a complex enterprise.
• Hands‑on architectural depth in federated data architecture, semantic layers, and multimodal data infrastructure.
• Able to operate as both strategist and technical leader.
• Experience with GxP data compliance in a regulated life sciences or biopharma environment strongly preferred.
• Understanding how data governance intersects with regulatory, clinical, and commercial data requirements.
• Deep familiarity with the current AI data landscape: vector databases, knowledge graphs, retrieval‑augmented generation, and modern data platforms that support enterprise AI workloads.
• Experience partnering with distributed engineering organizations.
• Successful experience governing data standards and architecture with a team in India or similar global delivery model is strongly preferred.
• Ability to communicate and influence effectively across Digital & Technology, business units, scientific functions, Legal, and Regulatory Affairs.
• Strong people leadership.
• Experience building and developing senior data engineering and governance talent in a competitive market.

We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law.

Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship.

Where necessary, we disclose salary ranges for roles in all countries in which we operate. The final offer will be determined within the relevant range based on the country of employment, specific role level, and your skills and experience. In some countries, collective bargaining agreements (CBAs) may apply and influence certain elements of pay or benefits.

Regeneron offers a competitive and comprehensive total rewards package which may include, depending on country and role:

• annual bonuses or other incentive plans
• equity awards
• pension or retirement benefits
• 401(k) company match
• health and wellness programs
• fitness centers
• insurance benefits (e.g. medical, dental, vision, life and disability)
• paid time off
• family support benefits

For additional information about Regeneron benefits in the U.S., please visit https://careers.regeneron.com/en/working-at-regeneron/total-rewards/. For other locations, additional information will be provided during the recruitment process.

As part of the recruitment process, certain background checks may be conducted in accordance with the laws of the country where the position is based. The purpose of such checks is to verify certain information prior to the commencement of employment such as identity, right to work and educational qualifications. For jobs in Canada: this posting is for an existing position.

Regeneron is a leading biotechnology company that invents life‑transforming medicines for people with serious diseases. Founded and led for over 30 years by physician‑scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA‑approved treatments and numerous product candidates in development, almost all of which were home‑grown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurology, infectious diseases and rare diseases. Regeneron is also proud of award winning culture of innovation, being recognized as a Great Place to Work in 2021, Fast Company’s Best Workplace for Innovators in 2020, Forbes JUST companies in 2020, among others.